{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:11:07Z","timestamp":1791670267807,"version":"4.3.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n Hidradenitis suppurativa (HS) is a painful and disfiguring chronic inflammatory skin disease. Despite many efforts over the past decade to improve the care of patients with HS, their satisfaction with medical care remains limited.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n The aim of this study was to assess the perceived involvement of patients with HS and, for comparison, patients with psoriasis, in treatment decision-making and to identify areas associated with positive perception.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A prospective, cross-sectional, questionnaire-based survey was conducted between May 2023 and July 2024 in different types of dermatological care facilities in Germany. Patients rated their therapy decision involvement and treatment satisfaction on a 0\u201310 scale. Data were stratified by demographic, clinical, and healthcare-related variables.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n 124 HS patients and 133 psoriasis patients completed the questionnaires. The percentage of HS patients rating their therapy decision involvement as low (values of 0\u20135) was 27.2%, while the percentage of psoriasis patients who gave the same assessment was 11.9% (\n P<\/jats:italic>\n &lt; 0.01). Moreover, the average degree of perceived therapy decision involvement was significantly lower for patients with HS compared to psoriasis patients (mean \u00b1 SD: 7.0 \u00b1 2.9 vs. 8.4 \u00b1 2.1;\n P<\/jats:italic>\n &lt; 0.001). Greater involvement in therapy decisions was linked to higher satisfaction of patients with the therapies received (\n P<\/jats:italic>\n &lt; 0.01). Younger HS patients (18\u201340 years) reported lower involvement scores (\n P<\/jats:italic>\n &lt; 0.01), while gender, education level, disease duration, disease severity, number of comorbidities, type of healthcare facility, and type of therapies undergone had no influence. Extended consultation times with the dermatologist (\u226520 min;\n P<\/jats:italic>\n &lt; 0.05) and more than one quarterly visit to the dermatologist (\n P<\/jats:italic>\n &lt; 0.01) were marginally associated with greater patient involvement in decision-making, but did not explain the difference between patients with HS and psoriasis in this regard. Waiting time until first visit to a dermatologist (negative association,\n P<\/jats:italic>\n &lt; 0.01) and, more strongly, satisfaction with information provided by the dermatologist about patient's skin disease (positive association,\n P<\/jats:italic>\n &lt; 0.001) were associated with patient involvement in therapy decision and were significantly different in patients with HS vs. psoriasis.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study shows limited involvement of HS patients in the therapy decision-making process, which was associated with low treatment satisfaction. Improvement may be achieved by training dermatologists in disease mechanisms and patient communication.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2025.1626345","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:14:19Z","timestamp":1756872859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient involvement in treatment decisions is associated with increased therapy satisfaction in Hidradenitis suppurativa"],"prefix":"10.3389","volume":"12","author":[{"given":"Giorgia","family":"Cugno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke","family":"Schneider-Burrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kokolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Wilsmann-Theis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rotraut","family":"Moessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk G.","family":"Bechara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nessr","family":"Abu Rached","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke K.","family":"Peitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Happ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Siddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kubitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durdana","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Vandersee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khusru","family":"Asadullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making\u2013pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"CD001431","DOI":"10.1002\/14651858.CD001431.pub6","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"1","author":"Stacey","year":"2024","journal-title":"Cochrane Database Syst Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamadermatol.2020.5362","article-title":"Shared decision-making in dermatology: a scoping review","volume":"157","author":"Morrison","year":"2021","journal-title":"JAMA Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","article-title":"Hidradenitis suppurativa","volume":"405","author":"Sabat","year":"2025","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.3390\/jcm9124046","article-title":"Prevalence of neuropathic pain and related characteristics in Hidradenitis suppurativa: a cross-sectional study","volume":"9","author":"Garcovich","year":"2020","journal-title":"J Clin Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jaad.2020.03.041","article-title":"The prevalence and odds of anxiety and depression in children and adults with Hidradenitis suppurativa: systematic review and meta-analysis","volume":"83","author":"Jalenques","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1159\/000448838","article-title":"High prevalence of back pain and axial spondyloarthropathy in patients with Hidradenitis suppurativa","volume":"232","author":"Schneider-Burrus","year":"2016","journal-title":"Dermatology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","article-title":"Overall and subgroup prevalence of Crohn disease among patients with Hidradenitis suppurativa: a population-based analysis in the United States","volume":"154","author":"Garg","year":"2018","journal-title":"JAMA Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jaad.2024.12.035","article-title":"Overall and subgroup prevalences of noninfectious uveitis among patients with Hidradenitis suppurativa","volume":"92","author":"Midgette","year":"2025","journal-title":"J Am Acad Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial infarction and cerebrovascular accident in patients with Hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/bjd.17578","article-title":"Substantially reduced life expectancy in patients with Hidradenitis suppurativa: a Finnish nationwide registry study","volume":"180","author":"Tiri","year":"2019","journal-title":"Br J Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/bjd.19556","article-title":"Aetiology and pathogenesis of Hidradenitis suppurativa","volume":"183","author":"Wolk","year":"2020","journal-title":"Br J Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3390\/biomedicines10082039","article-title":"Hidradenitis suppurativa: a perspective on genetic factors involved in the disease","volume":"10","author":"Moltrasio","year":"2022","journal-title":"Biomedicines."},{"key":"B15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ddg.14433","article-title":"Body mass index at the onset of Hidradenitis suppurativa","volume":"19","author":"van Straalen","year":"2021","journal-title":"J Dtsch Dermatol Ges."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in Hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in Hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Witte-Handel","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/bjd.17854","article-title":"A new T helper 17 cytokine in Hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26","volume":"181","author":"Scala","year":"2019","journal-title":"Br J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjd.19795","article-title":"Activity and components of the granulocyte colony-stimulating factor pathway in Hidradenitis suppurativa","volume":"185","author":"Wolk","year":"2021","journal-title":"Br J Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jaci.2022.10.034","article-title":"Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in Hidradenitis suppurativa","volume":"151","author":"Sabat","year":"2023","journal-title":"J Allergy Clin Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jid.2024.07.005","article-title":"Hepatocyte growth factor has unique functions in keratinocytes that differ from those of IL-17A and TNF and may contribute to inflammatory pathways in Hidradenitis suppurativa","volume":"145","author":"Shishido-Takahashi","year":"2025","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2409274121","DOI":"10.1073\/pnas.2409274121","article-title":"CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in Hidradenitis suppurativa","volume":"121","author":"Kashyap","year":"2024","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/bjd\/ljae469","article-title":"Long-term efficacy and safety of secukinumab in patients with moderate-to-severe Hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial","volume":"192","author":"Kimball","year":"2025","journal-title":"Br J Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2020.12.089","article-title":"The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of Hidradenitis suppurativa: results of a prospective European cohort study","volume":"85","author":"van Straalen","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/ced\/llaf160","article-title":"Is there still a role for clindamycin and rifampicin in the treatment of Hidradenitis suppurativa: a review of the literature","volume":"50","author":"Wainman","year":"2025","journal-title":"Clin Exp Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jaad.2015.07.049","article-title":"Scientific evidence for the use of current traditional systemic therapies in patients with Hidradenitis suppurativa","volume":"73","author":"Alhusayen","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e5860","DOI":"10.1097\/GOX.0000000000005860","article-title":"Surgical management of Hidradenitis suppurativa","volume":"12","author":"Krajewski","year":"2024","journal-title":"Plast Reconstr Surg Glob Open."},{"key":"B30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bjps.2021.08.038","article-title":"The surgical management of Hidradenitis suppurativa in the United Kingdom: a national survey of care pathways informing the THESEUS study","volume":"75","author":"Howes","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/bjd.18983","article-title":"Evidence for a 'window of opportunity' in Hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study","volume":"184","author":"Marzano","year":"2021","journal-title":"Br J Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s13555-024-01209-w","article-title":"Insights into the window of opportunity and outcome measures in patients with moderate to severe Hidradenitis suppurativa treated with secukinumab: a real-world study","volume":"14","author":"Haselgruber","year":"2024","journal-title":"Dermatol Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/ddg.14934","article-title":"The impact of surgical interventions on the psychosocial well-being of patients with Hidradenitis suppurativa","volume":"21","author":"Scholl","year":"2023","journal-title":"J Dtsch Dermatol Ges."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1384055","DOI":"10.3389\/fmed.2024.1384055","article-title":"Patient-reported assessment of medical care for chronic inflammatory skin diseases: an enterprise-based survey","volume":"11","author":"Wolk","year":"2024","journal-title":"Front Med."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20718.","article-title":"Low satisfaction with medical care among patients with Hidradenitis suppurativa: a multicenter study","author":"Wolk","year":"2025","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/bjd\/ljac027","article-title":"The impact of Hidradenitis suppurativa on professional life","volume":"188","author":"Schneider-Burrus","year":"2023","journal-title":"Br J Dermatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.det.2024.12.002","article-title":"Different phenotypes of Hidradenitis suppurativa","volume":"43","author":"Saeidi","year":"2025","journal-title":"Dermatol Clin."},{"key":"B38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaad.2024.03.008","article-title":"Full Guidelines-from the medical board of the national psoriasis foundation: perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis","volume":"91","author":"James","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"103287","DOI":"10.1016\/j.annder.2024.103287","article-title":"Treatment of moderate-to-severe psoriasis in adults: an expert consensus statement using a Delphi method to produce a decision-making algorithm","volume":"151","author":"Poizeau","year":"2024","journal-title":"Ann Dermatol Venereol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"T703","DOI":"10.1016\/j.ad.2025.05.010","volume":"116","author":"Ribera","year":"2025","journal-title":"Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS). Actas Dermosifiliogr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of Hidradenitis suppurativa","volume":"14","author":"von der Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.16783","article-title":"Hidradenitis suppurativa - prevalence analyses of German statutory health insurance data","volume":"35","author":"Schneider-Burrus","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of Hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis","year":"2020","journal-title":"Dermatology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"875492","DOI":"10.3389\/fmed.2022.875492","article-title":"Unmet medical needs in chronic, non-communicable inflammatory skin diseases","volume":"9","author":"Ujiie","year":"2022","journal-title":"Front Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40271-021-00539-7","article-title":"Identifying unmet care needs and important treatment attributes in the management of Hidradenitis suppurativa: a qualitative interview study","volume":"15","author":"Willems","year":"2022","journal-title":"Patient."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1626345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:14:20Z","timestamp":1756872860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1626345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":46,"alternative-id":["10.3389\/fmed.2025.1626345"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1626345","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1626345"}}